Medicine
Urate Lowering and Cardiovascular Risk-Extending the Benefits of a Treat-to-Target Strategy in Gout.
Pascal Richette, A. Latourte, Hang-Korng Ea
2026.1.26JAMA Internal Medicine
Abstract
Abstract is not available.
Citation format
RICHETTE, Pascal; LATOURTE, A.; EA, Hang-Korng. Urate lowering and cardiovascular risk-extending the benefits of a treat-to-target strategy in gout. JAMA Internal Medicine, 2026, 186(3): 342.